Lisuride Maleate

马来酸麦角乙脲

Report date: 2022/01/24 17:48:11
NME

Base Information

Drug NameLisuride Maleate
Drug Alias Name利舒脲Lisuride hydrogen maleate来酸麦角乙睬lisuridalisuride +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists +[5] 
TargetsDopamine D2 receptorSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor +[5] 
Therapy Area/IndicationsCocaine-Related DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute On Drug AbuseAxxonis Pharma Ag
Active IndicationsParkinson Disease
Inactive IndicationsCocaine-Related Disorders

Other Information

ATC CodeG02CB02N02CA07
Related LinksWikipediaDrugBankKEGG